tirzepatide for mash Newly released phase IIb 48-week liver biopsy data on #tirzepatide in #MASH. 73.9% resolution of with no worsening of fibrosis on 15 mg. Secondary endpoint ⬇️ fibrosis by >1 stage Consistent improvements in liver histology

Today, its most commonly taken as a dietary supplement, usually in capsule form

Lifestyle Integration: The success of Tirzepatide therapy is significantly enhanced by comprehensive lifestyle changes

If you are a wellness coach or fitness coach wondering how to tap into the GLP-1 and weight loss wave without building a clinic, loud marketing budgets, or complex tech stacks, you are in the right place

Decreased Glucagon Production: Semaglutide also reduces the production of glucagon, another hormone produced by the pancreas

Providers should approach compounding partnerships with thorough due diligence, transparent patient communication about the non-FDA-approved status of compounded products, and current legal guidance on the regulatory environment